​

Silence Therapeutics (SLN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Silence Therapeutics Revenue Highlights

Latest Revenue (Y)

$43.26M

Latest Revenue (Q)

$24.33M

Main Segment (Y)

Research Collaboration Income

Main Geography (Y)

GERMANY

Silence Therapeutics Revenue by Period

Silence Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$43.26M70.47%
2023-12-31$25.38M44.99%
2022-12-31$17.50M40.97%
2021-12-31$12.41M126.59%
2020-12-31$5.48M2145.49%
2019-12-31$244.00K100.00%
2018-12-31--100.00%
2017-12-31$16.00K-97.92%
2016-12-31$770.00K100.00%
2015-12-31--100.00%
2014-12-31$15.00K-87.18%
2013-12-31$117.00K-28.22%
2012-12-31$163.00K-76.51%
2011-12-31$694.00K-70.67%
2010-12-31$2.37M37.32%
2009-12-31$1.72M-22.00%
2008-12-31$2.21M-45.42%
2007-12-31$4.05M107.86%
2006-12-31$1.95M282.51%
2005-12-31$509.00K220.13%
2004-12-31$159.00K-88.17%
2003-12-31$1.34M16.77%
2002-12-31$1.15M734.06%
2001-12-31$138.00K-85.61%
2000-12-31$959.00K-30.00%
1999-12-31$1.37M552.38%
1998-12-31$210.00K100.00%
1997-12-31-100.00%
1996-12-31-100.00%
1995-12-31--

Silence Therapeutics generated $43.26M in revenue during NA 2024, up 70.47% compared to the previous quarter, and up 17728.69% compared to the same period a year ago.

Silence Therapeutics Revenue by Quarter

DateRevenueChange
2024-12-31$24.33M2030.28%
2024-09-30$1.14M90.97%
2024-06-30$598.00K-95.18%
2024-03-31$12.41M491.04%
2023-12-31$2.10M-24.98%
2023-09-30$2.80M-69.27%
2023-06-30$9.10M-19.96%
2023-03-31$11.37M138.70%
2022-12-31$4.76M41.35%
2022-09-30$3.37M-7.47%
2022-06-30$3.64M-36.33%
2022-03-31$5.72M67.60%
2021-12-31$3.41M8.17%
2021-09-30$3.16M16.85%
2021-06-30$2.70M-14.09%
2021-03-31$3.14M-473.40%
2020-12-31$-842.00K-142.35%
2020-09-30$1.99M246.95%
2020-06-30$573.00K-
2020-03-31$573.00K369.67%
2019-12-31$122.00K-
2019-09-30$122.00K100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30--

Silence Therapeutics generated $24.33M in revenue during Q4 2024, up 2030.28% compared to the previous quarter, and up 869.47% compared to the same period a year ago.

Silence Therapeutics Revenue Breakdown

Silence Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21
Royalty Income$100.00K$600.00K$600.00K-
Research Collaboration Income$43.10M$24.80M$16.90M$12.02M

Silence Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Research Collaboration Income (99.77%), and Royalty Income (0.23%).

Quarterly Revenue by Product

Product/ServiceMar 25
Research Collaboration Income$100.00K

Silence Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Research Collaboration Income (100.00%).

Silence Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23Dec 22Dec 21
GERMANY$144.00K$569.00K$578.00K$392.00K

Silence Therapeutics's latest annual revenue breakdown by geography, as of Dec 24: GERMANY (100.00%).

Silence Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TARSTarsus Pharmaceuticals$182.95M$78.33M
CTMXCytomX Therapeutics$138.10M$50.92M
GLUEMonte Rosa Therapeutics$75.62M$60.65M
SLNSilence Therapeutics$43.26M$24.33M
GNFTGenfit$28.57M$17.08M
CCCCC4 Therapeutics$20.76M$5.18M
RNAAvidity Biosciences$10.90M$2.97M
STTKShattuck Labs$5.72M-
IGMSIGM Biosciences$2.68M$412.00K
CDTXCidara Therapeutics$1.27M-
APLTApplied Therapeutics$455.00K-
OPTOpthea$108.41K$61.27K
CGEMCullinan Oncology--
NUVLNuvalent--
PRLDPrelude Therapeutics-$4.00M
CNTACentessa Pharmaceuticals--
MLYSMineralys Therapeutics--

SLN Revenue FAQ

What is Silence Therapeutics’s yearly revenue?

Silence Therapeutics's yearly revenue for 2024 was $43.26M, representing an increase of 70.47% compared to 2023. The company's yearly revenue for 2023 was $25.38M, representing an increase of 44.99% compared to 2022. SLN's yearly revenue for 2022 was $17.5M, representing an increase of 40.97% compared to 2021.

What is Silence Therapeutics’s quarterly revenue?

Silence Therapeutics's quarterly revenue for Q4 2024 was $24.33M, a 2030.28% increase from the previous quarter (Q3 2024), and a 1059.02% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $1.14M, a 90.97% increase from the previous quarter (Q2 2024), and a -59.19% decrease year-over-year (Q3 2023). SLN's quarterly revenue for Q2 2024 was $598K, a -95.18% decrease from the previous quarter (Q1 2024), and a -93.43% decrease year-over-year (Q2 2023).

What is Silence Therapeutics’s revenue growth rate?

Silence Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 147.17%, and for the last 5 years (2020-2024) was 689.52%.

What are Silence Therapeutics’s revenue streams?

Silence Therapeutics's revenue streams in c 24 are Royalty Income, and Research Collaboration Income. Royalty Income generated $100K in revenue, accounting 0.23% of the company's total revenue, down -83.33% year-over-year. Research Collaboration Income generated $43.1M in revenue, accounting 99.77% of the company's total revenue, up 73.79% year-over-year.

What is Silence Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Silence Therapeutics was Research Collaboration Income. This segment made a revenue of $43.1M, representing 99.77% of the company's total revenue.